Allarity Therapeutics, Inc. (ALLR) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-05-14

Allarity Therapeutics, Inc. (ALLR) has filed 3 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-05-14. 7 Form 8-K material event filings were reported by ALLR in the last 90 days. InsiderAlpha tracks every ALLR SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Allarity Therapeutics, Inc. (ALLR)

SIC classification	Pharmaceutical Preparations (SIC 2834)
SEC CIK	0001860657

90-Day SEC Filing Activity

Form 4 filings (90d)	3
Form 8-K filings (90d)	7
Latest Form 4 filing	2026-05-14

Recent ALLR Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-01-28	McLaughlin Gerald W.	Director	A — Grant or award	45.0K	$0.00	—	SEC
2026-01-28	Jensen Thomas	CEO	A — Grant or award	200.0K	$0.00	—	SEC
2026-01-07	Graff Jeremy R.	See Remarks	A — Grant or award	133.3K	$0.00	—	SEC
2026-01-07	Hoeiland Jesper	Director	A — Grant or award	25.0K	$0.00	—	SEC
2025-09-30	Graff Jeremy R.	See Remarks	F — Tax withholding / forfeiture	14.6K	$1.58	$23K	SEC
2025-09-30	Graff Jeremy R.	See Remarks	M — Option exercise	39.5K	—	—	SEC
2024-09-30	Graff Jeremy R.	See Remarks	A — Grant or award	118.5K	$2.11	$250K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Allarity Therapeutics, Inc. (ALLR). Updated in real time as new filings are submitted to the SEC.

Most-Active ALLR Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
McLaughlin Gerald W.	1	—
Hoeiland Jesper	1	—
Jensen Thomas	1	—

Recent ALLR Form 8-K Material Events

2026-07-01 — Item 5.07, 8.01, 9.01 [SEC]
2026-06-22 — Item 8.01, 9.01 [SEC]
2026-06-02 — Item 5.02, 9.01 [SEC]
2026-05-08 — Item 7.01, 8.01, 9.01 [SEC]
2026-05-06 — Item 8.01, 9.01 [SEC]

Recent Insider Filings

2026-05-14 — Jensen Thomas (CEO)
2026-05-11 — Hoeiland Jesper (Director)
2026-05-07 — McLaughlin Gerald W. (Director)
2026-01-16 — Graff Jeremy R. (See Remarks)
2025-09-30 — Graff Jeremy R. (See Remarks)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ALLR insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

ALLR Insider Trading — FAQ

What is the latest insider trade for ALLR?: Allarity Therapeutics, Inc. (ALLR) had 3 insider filings in the last 90 days, with the most recent on 2026-05-14. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ALLR stock?: 0 insider purchases of ALLR were filed in the last 90 days.
How many insiders are selling ALLR stock?: 0 insider sales of ALLR were filed in the last 90 days.
Where can I see ALLR SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every ALLR SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live ALLR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.